NEWS
RELEASE
Release: No. DITA-90
Date Mailed: Nov. 12, 2001
For Immediate Release
Contact: Ingri Cassel-208/265-2575;
800/336-9266
Public Health Expert Says Solving The
Anthrax Mailing Mystery
May Be Easy: FBI Doesn't Seem Interested
Sandpoint, ID -Cipro and smallpox
vaccine have much in common besides
capturing America's urgent attention in
recent weeks. The parent companies that
produce these favored elixirs for anthrax
and smallpox bioterrorism are linked,
strangely enough, to an infamous history
involving contaminated blood, the Central
Intelligence Agency (CIA), and even the
Nazis-associations that the FBI doesn't seem
anxious to explore.
Cipro is produced by Germany's Bayer AG,
while the smallpox vaccine's newly formed
producers are Acambis (previously OraVax),
partnered with Baxter and Aventis-created in
1999 by parent companies Hoechst and Rhone-Poulenc.
All have jaded histories.
The "Big Three"-Bayer, Baxter, and Rhone-Poulenc
are infamously known for having infected
more than 7,000 American hemophiliacs with
the AIDS virus during the early 1980s. They
admitted foreknowledge in selling
HIV-tainted blood clotting products and
settled the class action case for $100,000
per claimant.(1)
Bayer and Hoechst were formed following
World War II from the "decartelization" of
Germany's leading industrial organization
and Nazi economic engine-I.G. Farben. The
CIA immediately took over their vacated
corporate headquarters which had curiously
escaped allied bombings. Historians explain
that the Farben complex had been protected
by officials of John D. Rockefeller's
Standard Oil Company-half owner of the
Farben cartel. Many believe that Rockefeller
lawyer and Standard Oil business manager,
Allen Dulles, the CIA's first director,
military-command-protected Farben
headquarters from allied bombings. In the
current age when past CIA Director James
Woolsey lectures on "industrial espionage"
as a primary function of the modern
intelligence organization, this history may
have contemporary ramifications.
Soon after the CIA formed, Bayer and
Hoechst were reorganized in 1951 under the
direction of the Allied High Commission,
largely influenced by U.S. High Commissioner
John J. McCloy-a lawyer and banker from
Philadelphia, with intimate ties to
Rockefeller banking and oil interests. After
"decartelization," the I.G. Farben plants,
including all the labor camps involved in
the mostly Jewish genocide, were
consolidated into three main holding
companies: Bayer, Hoechst, and BASF for the
benefit of all the stockholders.
Hermann Schmitz, president of Bayer A.G
and I.G. Farben during WWII, who also
largely directed the Deutsche Bank, "held as
much stock in Standard Oil of New Jersey as
did the Rockefellers," according to former
CBS News war correspondent Paul Manning.
Acknowledging CIA director Dulles for his
information, Manning reported that on August
10, 1944, the Rockefeller-Farben partners
moved their "flight capital" through
affiliated German/French, American, British
and Swiss banks "for the new Germany." This
secured "the sophisticated distribution of
national and corporate assets to safe
havens" thoughout the world, and assured the
continuation and further development of the
"Neuordnung" (new order) for both the global
petrochemical pharmaceutical industry and
banking cartels.(2)
Given this generally unknown history, is
it surprising that the Secretary of the
Department of Health and Human Services (HHS),
Tommy Thompson, and other Bush cabinet
members have been meeting secretly (that is,
illegally) with officials of the
Pharmaceutical Research and Manufacturers of
America (PhRMA) to develop plans for their
Emergency Preparedness Task Force? The group
is said to be preparing enough drugs and
vaccines to protect every American against
the threats of anthrax and smallpox. PhRMA
task force officials, directed by Aventis
executive Richard Markham, and representing
a number of other Farben progeny and
beneficiaries including American Home
Products, Abbott Laboratories, Merck,
Pfizer, and more, according to the New York
Times (Nov. 4, 2001), have been meeting
regularly with Bush Cabinet members.
According to Dr. Sidney M. Wolfe, a director
at Ralph Nader's public Citizen Health
Research Group, the meetings violate a
federal law for transparency of
decision-making committees.(3)
Apparent illegalities did not deter
Secretary Thompson from ordering more than
$100 million worth of Cipro from Bayer at
the "bargain price" of $.90 per tablet, when
other companies offered equally effective
and lower risk substitutes for a few pennies
each, and then for free. On October 25,
2001, the health czar also asked Congress
for another $500 million to produce enough
of Acambis's smallpox vaccine "so every
American will be assured there is a dose
with his or her name on it if it is needed,"
even though CDC officials admit that people
already vaccinated probably shouldn't take
it, and the new remedy will require
extensive testing.(4,5)
Meanwhile, Acambis's sudden inexplicable
evolution in recent months from OraVax
corporation has some conspiracy theorists
wondering.(6) The OraVax firm had been
likewise linked to shady backroom dealings
with Clinton administration officials in
1998 regarding government orders for a yet
to be tested West Nile Virus vaccine. Dr.
Leonard Horowitz, a Public health consumer
advocate and author of Death in the Air:
Globalism, Terrorism and Toxic Warfare
(Tetrahedron Publishing Group;
1-888-508-4787), published months before the
9-11 terrorist attacks, explains that the
West Nile virus vaccine deal evolved from a
stealth meeting between Dr. Thomas Monath,
the Vice President of OraVax (now Acambis),
President Clinton, Janet Reno, CIA Director
John Deutsch, and American Type Culture
Collection (ATCC) curator Dr. Joshua
Lederberg, a former Rockefeller University
President and Council on Foreign Relations
bioterrorism study group leader. (7)
What concerns Dr. Horowitz most is not
that a business deal was struck, albeit
illegally, but that Dr. Lederberg had
falsely assured the American public that no
biological weapons were used during the Gulf
War despite his knowledge that the ATCC,
under his watch, sent nineteen shipments of
various strains of anthrax suitable for
weapons production to Sadam Hussein in the
years leading up to Desert Storm. The U.S.
Congress's Don Reigle hearings concerning
Gulf War syndrome exposed this fact about
ATCC, as well as their shipments of many
other biological weapons including the West
Nile Virus to Iraq that CDC officials
witnessed.(8)
"We have a very close working
relationship with many of the federal
agencies, including the FBI," said Nancy
Wysocki, a vice president at the ATCC,
during a recent New York Times interview
(November 9, 2001).(9)
"That's not particularly reassuring," Dr.
Horowitz said in response to Ms. Wysocki's
statement. "But it may explain why even
after hand delivering an urgent request to
the F.B.I. to investigate these devil-doers
for possible industrial espionage in the
anthrax mailings, they never even had the
courtesy to respond to my repeated
requests."
In fact, Dr. Horowitz first hand
delivered a memo to his regional F.B.I.
office on October 1, 2001, almost two weeks
before the first anthrax letter was sent
from Trenton, New Jersey to the American
media building in Boca Raton, Florida. His
action was prompted by reading, The Final
Report-the Oklahoma City bombing grand jury
investigation commissioned study by then
State Representative Charles Key. It stated
that German-based neo-Nazi's were known to
have "masterminded" both airline hijackings
and U.S. military installation bombings by
the PLO. This matched what the F.B.I. had
reported, and reinforced the German
connection to what was obviously a Cipro
sales "scam" reported by the Washington
Times.(4)
The F.B.I. also reported that the
silica-mixed anthrax powder required
expensive equipment, as well as a bioweapons
savvy microbiologist, to produce. They had
ruled out Islamic terrorist groups, but not
"state-sponsored" crimes. This likewise
suggested to Dr. Horowitz a "white collar
gang" was behind this crime.(9)
Then the New York Times (November 11,
2001) reported that F.B.I. agents were
denied access to "some pharmaceutical
companies in New Jersey." These ill-defined
companies demanded "agents to present a
subpoena before they would grant access to
their files."(9) Dr. Horowitz found this
additionally suspicious, if not seriously
incriminating, especially since Aventis, his
primary suspect, had two plants within
forty-five minutes drive from Trenton.
"I should think that any company with
nothing to hide would welcome the bureau's
inquiry especially at this time of dire
national urgency," Dr. Horowitz said. To him
the drug firms' response "exhibited a
Gestapo-like attitude."
"So after calling the F.B.I. in Miami and
getting nowhere, I even called their
1-800-CRIMETV number," Dr. Horowitz said.
After getting disconnected and then, on his
third attempt, put on hold for about ten
minutes, the Harvard-trained public health
investigator discussed his evidence with a
female F.B.I. agent. "Someone will get back
with you," she told him. No one ever did.
"I've asked the F.B.I. to thoroughly
investigate the possibility of industrial
espionage being perpetrated by Bayer
corporate officials as well as possibly Dr.
Thomas Monath, the Vice President of OraVax/Acambis
and affiliated officials at Aventis. I've
also urged an inquiry into ATCC curator Dr.
Joshua Lederberg, and the financial
interests he represents, including
Rockefeller pharmaceutical and banking
interests," Dr. Horowitz said.
The trouble is, as Dr. Horowitz admits,
this level of investigation may be
impossible for the F.B.I. to adequately
conduct. When it may implicate financial
forces of this magnitude, and even possibly
expose CIA undertakings, the bureau may be
politically ill-equipped to handle the
challenge.
"That's probably why I've been getting
nowhere in my efforts to direct the F.B.I.
where I believe the evidence is suggesting
they go," Dr. Horowitz concluded.
-end -
Note to journalists: For more information
on this subject, review copies of Dr.
Horowitz's books, or interviews with Dr.
Horowitz, please call Ingri Cassel at
1-888-508-4787.
1) Massie RK. Blood feud: A mother takes
the hemophilia tragedy to court. The New
Yorker. June 16, 1997, p. 98.
2) Manning P. Martin Bormann: Nazi in Exile.
Secaucus, NJ: Lyle Stuart, 1981, pp. 29, 56,
69, 116-17; 134-35.
3) Wolfe SM. Letter to HHS Secretary on
Pharmaceutical Research & Manufacturers of
America Emergency Preparedness Task Force (HRG
Publication #1600). Public Citizen.
Available at
http://www.citizen.org/publications/release.cfm?ID=7101.
4) O'Meara KP. Investigative Report:
Government ripoff on the Cipro deal.
Washington Times, Insight Magazine, Nov. 26,
2001. Available at
http://insightmag.com/main.cfm?include=detail&storyid=138294.
5) Charlotte D. Rules relaxed in rush for a
new smallpox vaccine. The Guardian,
Thursday, Oct. 25, 2001.
6) See:
http://www.oravax.com/
7) Horowitz LG. Death in the Air:
Globalism, Terrorism and Toxic Warfare.
Tetrahedron Publishing Group, 2001, pp.
105-109.
8) U.S. Senate, 103rd Congress, 2d Session.
U.S. Chemical and Biological Warfare-related
Dual Use Exports to Iraq and Their Possible
Impact on the Health Consequences of the
Persian Gulf War: A Report of Chairman
Donald W. Riegle, Jr., et. al. May 25, 1994,
pp. 39-47.
9) Broad WJ, Johnston D, Miller J and
Zielbauer P. Experts see F.B.I. missteps
hampering anthrax inquiry. New York Times,
Nov. 9, 2001. Available at
http://www.nytimes.com/2001/11/09/national/09INQU.html?todaysheadlines.
